Cannabinoids Collective Data Epilepsy 
Project CBD
MARCH 21, 2023
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” While the collective evidence to date is mixed and inconclusive, it’s also incomplete.
Veriheal
AUGUST 12, 2021
Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
NOVEMBER 1, 2023
Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains. 1 2 So why put CBDA in a body lotion?
Veriheal
FEBRUARY 21, 2023
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?
Cannabis Law Report
DECEMBER 7, 2021
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.
MedicalJane
JUNE 12, 2020
Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD. Study Findings. Fifty-eight percent of patients used CBD-dominant products.
The Joint Blog
MARCH 16, 2020
For the study researchers examined the use of marijuana over a 12-month period in a cohort of patients with chronic diseases, such as HIV, epilepsy, and fibromyalgia. We recruited patients with various chronic diseases who use cannabis and collected data regarding patterns of cannabis use as well as mental health, personality and QoL.
Expert insights. Personalized for you.
144 
Let's personalize your content